Johnson & Johnson (id:8469 JNJ)
155.75 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/21/2024 1:34:44 PM)
Exchange open, closes in 2 hours 25 minutes
About Johnson & Johnson
Market Capitalization 368.63B
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Headquarters (address) |
One Johnson & Johnson Plaza New Brunswick 08933 NJ United States |
Phone | 732 524 0400 |
Website | https://www.jnj.com |
Employees | 131,900 |
Sector | Healthcare |
Industry | Drug Manufacturers General |
Ticker | JNJ |
Exchange | New York Stock Exchange |
Currency | USD |
52 week range | 143.13 - 168.85 |
Market Capitalization | 368.63B |
Dividend yield forward | 3.24 % |
Dividend yield forward United States (ID:6, base:1863) | 4.22 % |
P/E trailing | 25.35 |
P/E forward | 14.44 |
Price/Sale | 4.20 |
Price/Book | 5.25 |
Beta | 0.518 |
EPS | 6.04 |
EPS United States (ID:6, base:3389) | 24.33 |
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Johnson & Johnson has raised their dividend 3.24 years in a row. This is below the 41113.895300 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Johnson & Johnson has raised their dividend 3.09 years in a row. This is below the 10.156100 year average in the 'Drug Manufacturers General' industry
Payout Ratio
Payout Ratio: Johnson & Johnson has raised their dividend 80.33 years in a row. This is below the 146.967900 year average in the 'Drug Manufacturers General' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Johnson & Johnson has raised their dividend 3.24 years in a row. This is below the 41113.895300 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Johnson & Johnson has raised their dividend 3.09 years in a row. This is below the 10.156100 year average in the 'Drug Manufacturers General' industry
Payout Ratio
Payout Ratio: Johnson & Johnson has raised their dividend 80.33 years in a row. This is below the 146.967900 year average in the 'Drug Manufacturers General' industry